Nivolumab Promising for Treatment of Advanced Cutaneous SCC
First-line nivolumab demonstrated antitumor activity and tolerability in a phase 2 trial of patients with aCSCC.
Source: cancertherapyadvisor.com
Page 4 - Squamous Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Squamous Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Squamous Cell Today - Breaking & Trending Today
Genexine's First-in-Class Therapeutic DNA Vaccine Shows Significant Potential to Extend Survival in Late-Stage Cervical Cancer
Late-Breaking presentation of phase 2 results from a clinical trial of GX-188E in combination with KEYTRUDA(pembrolizumab) demonstrates anti-tumor benefit in heavily pre-treated, recurrent and advanced
Source: finanznachrichten.de
German skin cancer patients join the EPIC-Skin study
/PRNewswire/ -- OncoBeta® GmbH has announced University Clinic of Rostock is participating in the global phase IV EPIC-Skin Study (Efficacy of Personalised...
Source: prnewswire.com
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
/PRNewswire/ -- OncoBeta® GmbH today announced Perth's Hollywood Private Hospital in Australia is the latest medical facility to participate in the global...
Source: prnewswire.com
Spectrum Health offers free skin cancer screenings in May
Skin cancer is the most common cancer in the United States.
Source: khou.com